1. LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer. (23rd October 2018) Authors: Ko, A H; Cubillo, A; Kundranda, M; Zafar, S F; Meiri, E; Bendell, J; Alguel, H; Rivera Herrero, F; Ahn, E; Watkins, D; Pelzer, U; Charu, V; Downing, W; Wang, B; Kuesters, G; Pipas, J M; Santillana, S L; Askoxylakis, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗